Sugi Predict

Sugi Predict / Compounds / SCHEMBL6519716

SCHEMBL6519716

SCHEMBL6519716

OC(c1cccc(-c2ccc3nc(-c4cnc5ccccc5c4)cn3c2)c1)C(O)c1cccc(-c2ccc3nc(-c4cscn4)cn3c2)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 6/20 0.46
▸ GRK5 P34947 2/20 0.42
▸ ALDH1A3 P47895 9/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ ALDH1A2 O94788 1/20 0.39
▸ KCNH2 Q12809 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ BIRC5 O15392 1/20 0.37
▸ SLC2A1 P11166 1/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ MAP4K4 O95819 1/20 0.34
▸ CSNK1G2 P78368 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ MKNK2 Q9HBH9 1/20 0.34
▸ MAP4K5 Q9Y4K4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6519711 0.86 NR4A2 (0.55) NR4A2GRK5ALDH1A3ALDH1A1ALDH1A2
SCHEMBL3432955 0.75 NR4A2 (0.65) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2
Hydrochloric Acid SCHEMBL6522828 0.74 NR4A2 (0.64) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2
SCHEMBL3411468 0.73 NR4A2 (0.67) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2
SCHEMBL3428756 0.72 NR4A2 (0.65) NR4A2GRK5ALDH1A3ALDH1A1ALDH1A2
SCHEMBL217708 0.71 ALDH1A3 (0.42) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2
SCHEMBL1460142 0.71 PDGFRB (0.59) GRK5BIRC5PDGFRBPDGFRAMAP4K4
Hydrochloric Acid SCHEMBL218759 0.71 ALDH1A3 (0.41) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2
Hydrochloric Acid SCHEMBL1472105 0.68 NR4A2 (0.74) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2
SCHEMBL3435794 0.68 NR4A2 (0.52) NR4A2ALDH1A3ALDH1A1ALDH1A2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123288-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (US) 2013-05-16 — — US disclosed
US-8338451-B2 Polysubstituted derivatives of 2-heteroaryl-6-phenylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI (FR) 2012-12-25 — — US disclosed
US-20110065727-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123288-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN NR4A2 1640/4885GRK5 864/4885ALDH1A3 1191/4885
US-20110065727-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN NR4A2 1640/4885GRK5 864/4885ALDH1A3 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.